Please assess the completion status of the following clinical trial:

Trial Title: Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Undergoing robotic assisted prostatectomy or robotic assisted partial nephrectomy at University of Missouri Hospital for prostate cancer or kidney mass~* Age ≥ 18 years~* ASA I-III~Exclusion Criteria:~* Inability to obtain written informed consent~* Allergy to lidocaine or other amide local anesthetics~* Atrioventricular conduction blocks~* CV instability and concomitant use of alpha agonists or beta blockers~* Recent myocardial infarction (≤ 6 months ago)~* Cardiac arrhythmia disorders~* Stokes-Adams syndrome~* Wolff-Parkinson-White syndrome~* Seizure disorders~* Liver failure or hepatic dysfunction~* Significant renal disease with a serum creatinine ≥ 2 mg/dl~* A family history of malignant hyperthermia~* Current use of opioids or documented history of opioid abuse~* Typically, have less than 3 bowel movement per week~* Combined surgical cases that include robotic prostatectomy or robotic partial nephrectomy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment group (Type: ACTIVE_COMPARATOR): Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution
- Control group (Type: PLACEBO_COMPARATOR): 0.9% Sodium Chloride Injection

Based on this trial design, predict the completion outcome and termination type (if applicable).